Select Publications

Journal articles

Nourse G; Farrugia A; Fraser S; Moore D; Treloar C, 2023, 'Optimism and eternal vigilance: Gathering disease, responsible subjects and the hope of elimination in the new hepatitis C treatment era', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104142

Conway A; Krawczyk N; McGaffey F; Doyle S; Baaklini V; Marshall AD; Treloar C; Davis CS; Colledge-Frisby S; Grebely J; Cerdá M, 2023, 'Typology of laws restricting access to methadone treatment in the United States: A latent class analysis', International Journal of Drug Policy, 119, http://dx.doi.org/10.1016/j.drugpo.2023.104141

Broady TR; Brener L; Horwitz R; Cama E; Treloar C, 2023, 'Reducing stigma towards people living with HIV and people who inject drugs using social norms theory: An online study with Australian health care workers', Drug and Alcohol Dependence, 249, http://dx.doi.org/10.1016/j.drugalcdep.2023.109953

Marshall AD; Schroeder SE; Lafferty L; Drysdale K; Baldry E; Stoové M; Dietze P; Higgs P; Treloar C, 2023, 'Perceived access to opioid agonist treatment in prison among people with a history of injection drug use: A qualitative study', Journal of Substance Use and Addiction Treatment, 150, http://dx.doi.org/10.1016/j.josat.2023.209066

Schroeder SE; Treloar C; Bourne A; Stoové M; Doyle J; Hellard M; Pedrana A, 2023, 'Pre-Empting Stigma and Complicating Trauma: Narratives of Gay and Bisexual Men who Inject Drugs in Australia', Qualitative Health Research, 33, pp. 688 - 700, http://dx.doi.org/10.1177/10497323231173788

Wand H; Reilly R; McKetin R; Quinn B; Roe Y; Conigrave K; Ezard N; Butt J; Treloar C; Sivak L; Shackleford I; Dunlop A; Ward J, 2023, 'Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples', Mental Health and Prevention, 30, http://dx.doi.org/10.1016/j.mhp.2023.200267

Lafferty L; Sheehan Y; Cochrane A; Grebely J; Lloyd AR; Treloar C, 2023, 'Reducing barriers to the hepatitis C care cascade in prison via point-of-care RNA testing: a qualitative exploration of men in prison using an integrated framework', Addiction, 118, pp. 1153 - 1160, http://dx.doi.org/10.1111/add.16137

Clay S; Treloar C; Degenhardt L; Grebely J; Christmass M; Gough C; Hayllar J; McDonough M; Henderson C; Crawford S; Farrell M; Marshall A, 2023, '‘I just thought that was the best thing for me to do at this point’: Exploring patient experiences with depot buprenorphine and their motivations to discontinue', International Journal of Drug Policy, 115, http://dx.doi.org/10.1016/j.drugpo.2023.104002

Conway A; Treloar C; Crawford S; Degenhardt L; Dore GJ; Farrell M; Hayllar J; Grebely J; Marshall AD, 2023, '“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103998

Marshall AD; Martinello M; Zolopa C; Treloar C; Larney S, 2023, 'Universal hepatitis C virus screening and treatment as part of prenatal care', The Lancet Gastroenterology and Hepatology, 8, pp. 295 - 297, http://dx.doi.org/10.1016/S2468-1253(22)00421-6

Broady TR; Brener L; Caruana T; Cama E; Treloar C, 2023, 'Factors associated with sharing equipment among people who inject drugs: The role of community attachment in harm reduction and health promotion', Drug and Alcohol Review, 42, pp. 561 - 568, http://dx.doi.org/10.1111/dar.13606

Lancaster K; Gendera S; Treloar C; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2023, 'The Social, Material, and Temporal Effects of Monthly Extended-Release Buprenorphine Depot Treatment for Opioid Dependence: An Australian Qualitative Study', Contemporary Drug Problems, 50, pp. 105 - 120, http://dx.doi.org/10.1177/00914509221140959

Fomiatti R; Farrugia A; Fraser S; Moore D; Edwards M; Treloar C, 2023, 'Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment', Time and Society, 32, pp. 50 - 74, http://dx.doi.org/10.1177/0961463X221128736

Graham S; Martin K; Gardner K; Beadman M; Doyle MF; Bolt R; Murphy D; Newman CE; Bell S; Treloar C; Browne AJ; Aggleton P; Beetson K; Brooks M; Botfield JR; Davis B; Wilms J; Leece B; Stanbury L; Bryant J, 2023, 'Aboriginal young people’s perspectives and experiences of accessing sexual health services and sex education in Australia: A qualitative study', Global Public Health, 18, pp. 2196561, http://dx.doi.org/10.1080/17441692.2023.2196561

Treloar C; Idle J; valentine K, 2023, 'Child Sexual Abuse, Alcohol and Other Drug use and the Criminal Justice System: The Meanings of Trauma in Survivor Narratives for a National Royal Commission', Qualitative Health Research, 33, pp. 117 - 126, http://dx.doi.org/10.1177/10497323221144923

Peterie M; Broom A; Kenny K; Broom J; Regan D; Lafferty L; Kelly-Hanku A; Treloar C, 2023, 'Economies of resistance', Critical Public Health, 33, pp. 763 - 775, http://dx.doi.org/10.1080/09581596.2023.2271140

Martin K; Bryant J; Beetson K; Wilms J; Briggs T; Treloar C; Newman C, 2023, 'Normalising sex and resisting shame: young Aboriginal women’s views on sex and relationships in an urban setting in Australia', Journal of Youth Studies, ahead-of-print, pp. 1 - 17, http://dx.doi.org/10.1080/13676261.2023.2225422

Conway A; Treloar C; Crawford S; Grebely J; Marshall AD, 2023, 'People engaged in opioid agonist treatment as a counterpublic during the COVID-19 pandemic in Australia: A qualitative study', Drug and Alcohol Review, 42, pp. 203 - 212, http://dx.doi.org/10.1111/dar.13531

Brener L; Broady T; Cama E; Treloar C, 2023, 'The impact of sources of stigma on health care avoidance among gay and bisexual men in Australia', AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV, 35, pp. 663 - 671, http://dx.doi.org/10.1080/09540121.2022.2057410

Lafferty L; Schroeder S; Marshall AD; Drysdale K; Higgs P; Stoové M; Baldry E; Dietze P; Treloar C, 2023, 'Trust and service engagement among people who inject drugs after release from prison', International Journal of Drug Policy, 111, http://dx.doi.org/10.1016/j.drugpo.2022.103925

Broom A; Peterie M; Kenny K; Broom J; Kelly-Hanku A; Lafferty L; Treloar C; Applegate T, 2023, 'Vulnerability and antimicrobial resistance', Critical Public Health, 33, pp. 308 - 317, http://dx.doi.org/10.1080/09581596.2022.2123733

Treloar C; Cama E; Lancaster K; Brener L; Broady TR; Cogle A; O’Donnell D, 2022, 'A universal precautions approach to reducing stigma in health care: getting beyond HIV-specific stigma', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00658-w

Valerio H; Conway A; Alavi M; Treloar C; Silk D; Murray C; Henderson C; Amin J; Read P; Degenhardt L; Christmass M; Montebello M; Dore GJ; Grebely J, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876

Silano JA; Treloar C; Leadbeatter K; Davidson S; Doidge J, 2022, 'Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project', Harm Reduction Journal, 19, http://dx.doi.org/10.1186/s12954-022-00619-3

Silano JA; Treloar C; Wright T; Brown T; McGrath C; Snoyman P, 2022, 'Commentary on the harm reduction reference group of justice health and forensic mental health network and corrective services NSW, Australia', International Journal of Prisoner Health, 18, pp. 394 - 406, http://dx.doi.org/10.1108/IJPH-06-2021-0050

Wallace J; Richmond J; Howell J; Hajarizadeh B; Power J; Treloar C; Revill PA; Cowie B; Wang S; Stoové M; Pedrana A; Hellard M, 2022, 'Exploring the Public Health and Social Implications of Future Curative Hepatitis B Interventions', Viruses, 14, http://dx.doi.org/10.3390/v14112542

Carson JM; Dore GJ; Lloyd AR; Grebely J; Byrne M; Cunningham E; Amin J; Vickerman P; Martin NK; Treloar C; Martinello M; Matthews GV; Hajarizadeh B, 2022, 'Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study', Clinical Infectious Diseases, 75, pp. 1809 - 1819, http://dx.doi.org/10.1093/cid/ciac246

Zhang Y; Guy R; Camara H; Applegate TL; Wiseman V; Treloar C; Lafferty L, 2022, 'Barriers and facilitators to HIV and syphilis rapid diagnostic testing in antenatal care settings in low-income and middle-income countries: A systematic review', BMJ Global Health, 7, pp. e009408, http://dx.doi.org/10.1136/bmjgh-2022-009408

Jin D; Brener L; Treloar C, 2022, 'Hepatitis B-related stigma among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Health and Social Care in the Community, 30, pp. e5602 - e5611, http://dx.doi.org/10.1111/hsc.13986

Marshall AD; Martinello M; Treloar C; Matthews GV, 2022, 'Perceptions of hepatitis C treatment and reinfection risk among HIV-positive men who have sex with men and engage in high risk behaviours for hepatitis C transmission: The CEASE qualitative study', International Journal of Drug Policy, 109, http://dx.doi.org/10.1016/j.drugpo.2022.103828

Jin D; Brener L; Treloar C, 2022, 'Trust in healthcare providers among Chinese immigrants living with hepatitis B virus in Australia: A qualitative study', Journal of Viral Hepatitis, 29, pp. 968 - 975, http://dx.doi.org/10.1111/jvh.13736

Drysdale K; Rance J; Cama E; Treloar C; Mao L, 2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066

Treloar C; Lancaster K; Gendera S; Rhodes T; Shahbazi J; Byrne M; Degenhardt L; Farrell M, 2022, 'Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot', International Journal of Drug Policy, 107, pp. 103788, http://dx.doi.org/10.1016/j.drugpo.2022.103788

Fraser S; Moore D; Farrugia A; Fomiatti R; Edwards M; Birbilis E; Treloar C, 2022, 'Exhausted practical sovereignty and lateral agency: Non-uptake of treatment for hepatitis C in the antiviral era', International Journal of Drug Policy, 107, http://dx.doi.org/10.1016/j.drugpo.2022.103771

Lafferty L; Rance J; Byrne M; Milat A; Dore GJ; Grebely J; Lloyd AR; Treloar C, 2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746

Wheeler A; Valerio H; Cunningham EB; Martinello M; Barocas JA; Colledge-Frisby S; Treloar C; Amin J; Henderson C; Read P; Matthews GV; Dunlop AJ; Gorton C; Hayllar J; Alavi M; Murray C; Marks P; Silk D; Degenhardt L; Dore GJ; Grebely J, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543

Conway A; Valerio H; Alavi M; Silk D; Treloar C; Hajarizadeh B; Marshall AD; Martinello M; Milat A; Dunlop A; Murray C; Prain B; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Hayllar J; Reid D; Gorton C; Lam T; Christmass M; Wade A; Montebello M; Dore GJ; Grebely J, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555

Brener L; Caruana T; Broady T; Cama E; Ezard N; Madden A; Treloar C, 2022, 'Addressing injecting related risks among people who inject both opioids and stimulants: Findings from an Australian survey of people who inject drugs', Addictive Behaviors Reports, 15, pp. 100398, http://dx.doi.org/10.1016/j.abrep.2021.100398

Gendera S; Treloar C; Reilly R; Conigrave KM; Butt J; Roe Y; Ward J, 2022, '‘Even though you hate everything that’s going on, you know they are safer at home’: The role of Aboriginal and Torres Strait Islander families in methamphetamine use harm reduction and their own support needs', Drug and Alcohol Review, 41, pp. 1 - 12, http://dx.doi.org/10.1111/dar.13481

Larney S; Madden A; Marshall AD; Martin NK; Treloar C, 2022, 'A gender lens is needed in hepatitis C elimination research', International Journal of Drug Policy, 103, http://dx.doi.org/10.1016/j.drugpo.2022.103654

Jin D; Brener L; Treloar C, 2022, 'Knowledge and beliefs about hepatitis B virus infection and associated factors among Chinese migrants in Australia: The result of a quantitative study', Health and Social Care in the Community, 30, pp. 918 - 925, http://dx.doi.org/10.1111/hsc.13239

Marshall AD; Rance J; Grebely J; Treloar C, 2022, '‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective', International Journal of Drug Policy, 102, http://dx.doi.org/10.1016/j.drugpo.2022.103610

Farrugia A; Fomiatti R; Fraser S; Moore D; Edwards M; Birbilis E; Treloar C, 2022, 'Hepatitis C cure as a ‘gathering’: Attending to the social and material relations of hepatitis C treatment', Sociology of Health and Illness, 44, pp. 830 - 847, http://dx.doi.org/10.1111/1467-9566.13467

Schroeder SE; Drysdale K; Lafferty L; Baldry E; Marshall AD; Higgs P; Dietze P; Stoove M; Treloar C, 2022, '"It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success', International Journal of Drug Policy, 101, pp. 103571, http://dx.doi.org/10.1016/j.drugpo.2021.103571

Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR, 2022, '“That was quick, simple, and easy”: Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103456

Brener L; Cama E; Broady T; Hopwood M; Treloar C, 2022, 'Comparing Australian health worker and student attitudes and concerns about providing care to people living with hepatitis B', Health Promotion Journal of Australia, 33, pp. 282 - 288, http://dx.doi.org/10.1002/hpja.475

Jin D; Treloar C; Brener L, 2022, 'Hepatitis B virus related stigma among Chinese living in mainland China: a scoping review', Psychology, Health and Medicine, 27, pp. 1760 - 1773, http://dx.doi.org/10.1080/13548506.2021.1944651

Farrugia A; Treloar C; Fraser S, 2022, 'Overdoselifesavers.org: a mixed-method evaluation of a public information website on experiences of overdose and using take-home naloxone to save lives', Drugs: Education, Prevention and Policy, 29, pp. 43 - 53, http://dx.doi.org/10.1080/09687637.2020.1858758

Karlsen TH; Sheron N; Zelber-Sagi S; Carrieri P; Dusheiko G; Bugianesi E; Pryke R; Hutchinson SJ; Sangro B; Martin NK; Cecchini M; Dirac MA; Belloni A; Serra-Burriel M; Ponsioen CY; Sheena B; Lerouge A; Devaux M; Scott N; Hellard M; Verkade HJ; Sturm E; Marchesini G; Yki-Järvinen H; Byrne CD; Targher G; Tur-Sinai A; Barrett D; Ninburg M; Reic T; Taylor A; Rhodes T; Treloar C; Petersen C; Schramm C; Flisiak R; Simonova MY; Pares A; Johnson P; Cucchetti A; Graupera I; Lionis C; Pose E; Fabrellas N; Ma AT; Mendive JM; Mazzaferro V; Rutter H; Cortez-Pinto H; Kelly D; Burton R; Lazarus JV; Ginès P; Buti M; Newsome PN; Burra P; Manns MP, 2022, 'The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality', The Lancet, 399, pp. 61 - 116, http://dx.doi.org/10.1016/S0140-6736(21)01701-3

Valerio H; Alavi M; Conway A; Silk D; Treloar C; Martinello M; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Grebely J; ETHOS Engage Study Group , 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study.', Int J Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706


Back to profile page